Skip to main content
SpringerLink
Log in
Book cover

Klinische Endokrinologie für Frauenärzte pp 349–371Cite as

Störungen des Prolaktinhaushalts

  • Chapter

Zusammenfassung

Klinische Bedeutung des Prolaktins und seiner Sekretionsstörungen. In der gynäkologischen Sprechstunde wird die Hyperprolaktinämie im Zusammenhang mit Zyklusstörungen als eine der häufigsten endokrinen Störungen diagnostiziert. Prolaktin nimmt eine zentrale Bedeutung in der Reproduktionsendokrinologie ein. Eine gestörte Prolaktinsekretion kann außer mit einer Funktionsstörung des Ovars auch mit Funktionsstörungen anderer endokriner Organe wie der Schilddrüse und der Nebennierenrinde verbunden sein. Auf der anderen Seite ist eine gestörte Prolaktinsekretion u. U. selbst Symptom und Begleiterscheinung anderer Endokrinopathien, Stoffwechselstörungen oder Allgemeinerkrankungen (s. nachfolgende übersicht). Daher stellt die Bestimmung des Prolaktinspiegels im Blut eine der zentralen differenzialdiagnostischen Maßnahmen in der Abklärung von Hormon- und Fertilitätsstörungen dar.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alvarez C, Alonso-Muriel I, Garcfa G et al. (2007) Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 22: 3210–3214

    Article  PubMed  CAS  Google Scholar 

  • Andersen M, Hagen C, Frystyk J, Schroeder HD, Hagen C (2003) Development of acromegaly in patients with prolactinomas. Eur J Endocrinol 149: 17–22

    Article  PubMed  CAS  Google Scholar 

  • Archer DF, Josimovich JB (1975) Response of serum prolactin to exogenous stimulation. Fertil Steril 26: 627

    PubMed  CAS  Google Scholar 

  • Asa SL, Penz G, Kovacs K, Ezrin C (1982) Prolactin cells in the human pituitary. Arch Pathol Lab Med 106: 360

    PubMed  CAS  Google Scholar 

  • Bals-Pratsch M, De Geyter C, Müller T et al. (1997) Episodic variations of prolactin, TSH, LH, melatonin and cortisol and relationship to sleep stages in infertile women with subclinical hypothyroidism. Hum Reprod 12: 896–904

    Article  PubMed  CAS  Google Scholar 

  • Bals-Pratsch M, Schober O, Hanker JP, de Geyter C, Schneider HPG (1993) Schilddrüsenfunktionsstörungen und Sterilität der Frau. Zentralbl Gynäkol 115: 118–223

    Google Scholar 

  • Bayrak A, Saadat P, Mor E, Chong L, Paulson RJ, Sokol RZ (2005) Pituitary imaging is indicated for the evaluation of hyperprolactinemia Fertil Steril 84: 181–185

    Article  PubMed  Google Scholar 

  • Ben-David M, Schenker JG (1983) Transient hyper-prolactinemia: a correctable cause of idiopathic female infertility. J Clin Endocrinol Metab 57: 442

    Article  PubMed  CAS  Google Scholar 

  • Bohnet HG (1981) Prolaktin und seine Bedeutung für die Frau. Grosse, Berlin

    Google Scholar 

  • Bohnet HG (1986) Hyperprolaktinämie. Grosse, Berlin

    Google Scholar 

  • Bohnet HG, Dahlen HG, Wuttke W, Schneider HPG (1976) Hyperprolactinemic anovulatory syndrome. J Clin Endocrinol Metab 42: 132

    Article  PubMed  CAS  Google Scholar 

  • Bohnet HG, Fiedler K, Leidenberger FA (1981) Subclinical hypothyreoidism and infertility. Lancet II: 1278

    Article  Google Scholar 

  • Bohnet HG, Kato K, Niemann D (1986) Thyroid function and prolactin secretion in women with menstrual disorders and/or infertility. In: Medeiros-Neto G, Gaitan E (eds) Frontiers in thyroidology I. Plenum, New York, p 270

    Google Scholar 

  • Bonhoff A, Vuille JC, Gomez F, Gellersen B (1995) Identification of macroprolactin in a patient with asymptomatic hyperprolactinemia as a stable PRL-IgG complex. Exp Clin Endocrinol 103: 252

    Article  CAS  Google Scholar 

  • Brue T, Pellegrini I, Priou A et al. (1992) Prolactinomas and resistance to dopamine agonists. Horm Res 38: 84

    Article  PubMed  CAS  Google Scholar 

  • Buckman MR, Peake GT, Srivastava L (1981) Patterns of spontaneous LH release in normo-and hyper-prolactinaemic women. Acta Endocrinologica 97: 305

    PubMed  CAS  Google Scholar 

  • Colao A, Abs R, Bärcena DG, Chanson P, Paulus W, Kleinberg DL (2008) Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.Clin Endocrinol (Oxf) 68: 66–71

    CAS  Google Scholar 

  • Cowie AT, Tindal JS (1971) The physiology of lactation. In: Dawson H, Greenfield ADM, Whittam R, Brindley GS (eds) Monographs of the physiological society, 22. Edward Arnold Ltd., London, p 105

    Google Scholar 

  • Crosignani PG (2006) Current treatment issues in female hyperprolactinaemia. Eur J Obstet Gynecol Reprod Biol 125: 152–164

    Article  PubMed  CAS  Google Scholar 

  • Denef C, Andries M (1983) Evidence for paracrine interaction between gonadotrophs and lactotrophs in pituitary cell aggregates. Endocrinol 112: 813

    Article  CAS  Google Scholar 

  • Divers WA, Yen SSC (1983) Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 62: 425

    PubMed  Google Scholar 

  • Evans WS, Thorner MO (1984) Mechanisms for hypogonadism in hyperprolactinaemia. Sem Reprod Endocrinol 2: 9

    Article  Google Scholar 

  • Fahlbusch R, Nistor R, Buchfelder M, Huk W (1988) Imaging magnetic resonance (MEI) in the preoperative diagnosis of pituitary adenomas: a comparison with CT. In: Landolt AM et al. (eds) Advances in pituitary adenoma research. Pergamon, Oxford, p 117

    Google Scholar 

  • Falk RJ (1992) Isolated prolactin deficiency: a case report. Fertil Steril 58: 1060

    PubMed  CAS  Google Scholar 

  • Fink U, Bauer WM, Hartmann N et al. (1988) Efficiency of MRI in patients with pituitary adenomas. In: Landolt AM et al. (eds) Advances in pituitary adenoma research. Pergamon, Oxford, p 1

    Google Scholar 

  • Fish LH, Mariash CN (1988) Hyperprolactinemia, infertility and hypothyroidism. Arch Intern Med 148: 709–711

    Article  PubMed  CAS  Google Scholar 

  • Franks S, Murray AF, Jequier AM et al. (1975) Incidence and significance of hyperprolactinaemia in women with amenorrhoea. Clin Endocrinol 4: 597

    Article  CAS  Google Scholar 

  • Gellersen B, DiMattia GE, Friesen HG, Bohnet HG (1989) Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript. Mol Cell Endocrinol 64: 127

    Article  PubMed  CAS  Google Scholar 

  • Ginsburg J, Hardiman P, Thomas M (1991) Vaginal bromocriptine. Letter. Lancet 338ii: 1205–1206

    Google Scholar 

  • Glasow A, Breidert M, Haidan A et al. (1996) Functional aspects of the effects of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal gland. J Clin Endocrinol Metab 81: 3103

    Article  PubMed  CAS  Google Scholar 

  • Gomez F, Reyes FI, Faiman C (1977) Nonpuerperal galactorrhea and hyperprolactinemia. Am J Med 62: 648

    Article  PubMed  CAS  Google Scholar 

  • Grossman A (1987) Opioid peptides and reproductive function. Sem Reprod Endocrinol 5: 115

    Article  Google Scholar 

  • Hamon-Kérautret M, Leclerc X, Dewailly D, Pruvo JP, Fossati P, Clarisse J (1994) Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa. Eur J Radiol 18: 185–190

    Article  PubMed  Google Scholar 

  • Ivân G, Szigeti-Csúcs N, Olâh M, Nagy GM, Gáth MI (2005) Treatment of pituitary tumors: dopamine agonists. Endocrine 28: 101–110

    Article  PubMed  Google Scholar 

  • Jackson RD, Wortsman J, Malarkey WB (1985) Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 61: 258

    Article  PubMed  CAS  Google Scholar 

  • Jara LJ, Cruz-Cruz P, Saavedra MA et al. (2007) Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci 1110: 297–304

    Article  PubMed  CAS  Google Scholar 

  • Johnston JM, Amico JA (1986) A prospective longitudinal study of the release of oxytocin and prolactin in response to infant suckling in long term lactation. J Clin Endocrinol Metab 62: 653–657

    Article  PubMed  CAS  Google Scholar 

  • Jürgensen O, Bardee B (1982) Zur Psychodynamik der Hyperprolaktinämie. Gynäkologe 15: 190

    PubMed  Google Scholar 

  • Kars M, Pereira AM, Bax JJ, Romijn JA (2008) Cabergoline and cardiac valve disease in prolactinoma patients: additional studies during long-term treatment are required. Eur J Endocrinol 159:363–367

    Article  PubMed  CAS  Google Scholar 

  • Kleinberg DL (1984) Medical treatment of pituitary tumors. Sem Reprod Endocrinol 2: 63

    Article  Google Scholar 

  • Kletzky OA (1984) Diagnostic approaches to hyperprolactinemic states. Sem Reprod Endocrinol 2: 23

    Article  Google Scholar 

  • Klibanski A (1984) Osteoporosis and hyperprolactniemia. Sem Reprod Endocrinol 2: 93

    Article  Google Scholar 

  • Klibanski A, Neer RM, Beitins IZ et al. (1980) Decreased bone density in hyper-prolactinemic women. N Engl J Med 303: 1511

    Article  PubMed  CAS  Google Scholar 

  • Koppelman MCS, Kurtz DW, Morrish KA et al. (1984) Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab 59: 1050

    Article  PubMed  CAS  Google Scholar 

  • Kreft B, Peters A, Kerner W (1996) The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation. Dtsch Med Wochenschr 121: 865–868

    Article  PubMed  CAS  Google Scholar 

  • Lappöhn RE, van de Wiel HBM, Brownell J (1992) The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia. Fertil Steril 58: 321

    PubMed  Google Scholar 

  • Larrea F, Sandoval JL, Salinas E et al. (1995) Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia. Clin Endocrinol 43: 591

    Article  CAS  Google Scholar 

  • Lengyel AMJ, Mussio W, Imamura P et al. (1993) Long-acting injectable bromocriptin (Parlodel LAR) in the chronic treatment of prolactinsecreting macroadenomas. Fertil Steril 59: 980

    PubMed  CAS  Google Scholar 

  • Leyendecker G, Nocke W, Schmidt-Gollwitzer M et al. (1977) Klinik der hyperprolaktinämischen Amenorrhoe. Gynäkologe 10: 93

    Google Scholar 

  • Lobo RA, Kletzky OA, Kaptein EM, Goebelsmann U (1980) Prolactin modulation of dehydroepiandrosterone sulfate secretion. Am J Obstet Gynecol 138: 632

    PubMed  CAS  Google Scholar 

  • Loucopoulos A, Jewelewicz R (1984) Prolactinomas and pregnancy. Sem Reprod Endocrinol 2: 83

    Article  Google Scholar 

  • Lüdecke DK, Herrmann HD, Hörmann C, Desaga U, Saeger W (1983) Microsurgery and combination with dopamine agonists in the treatment of prolactinomas. In: Tolis G et al. (eds) Prolactin and prolactinomas. Raven, New York, p 453

    Google Scholar 

  • Marchetti B, Labrie F (1982) Prolactin inhibits pituitary luteinizing hormone-releasing hormone receptors in the rat. Endocrinology 111: 1209

    Article  PubMed  CAS  Google Scholar 

  • Marcovitz S, Hardy J (1984) Combined medical and surgical treatment of prolactin-producing pituitary tumors. Sem Reprod Endocrinology 2: 73

    Article  Google Scholar 

  • McNatty JP, Sawers RS, McNeilly AS (1974) A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature 250: 653

    Article  PubMed  CAS  Google Scholar 

  • Meema S, Bunker ML, Meema HE (1975) Preventive effect of estrogen on postmenopausal bone loss: a follow-up study. Arch Intern Med 135: 1436

    Article  PubMed  CAS  Google Scholar 

  • Melmed S (1984) Control of prolactin synthesis and secretion. Sem Reprod Endocrinol 2: 1

    Article  Google Scholar 

  • Missale C, Losa M, Sigala S et al. (1996) Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Mol Endocrinol 10: 272

    Article  PubMed  CAS  Google Scholar 

  • Molitch ME (1985) Pregnancy and the hyperprolactinemic women. N Engl J Med 312: 1364

    PubMed  CAS  Google Scholar 

  • Moltz L, Trapp M, Bispink G, Leidenberger F (1987) Rationelle hormonale Diagnostik der sekundären Amenorrhö. Geburtshilfe Frauenheilkd 47: 228

    Article  PubMed  CAS  Google Scholar 

  • Moult PJA, Rees LH, Besser GM (1982) Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea and the response to bromocriptine therapy. Clin Endocrinol 16: 153

    Article  CAS  Google Scholar 

  • Nikolics K, Mason AJ, Szonyi E et al. (1985) A prolactin-inhibiting factor within the precursor for human gonadotropin-releasing hormone. Nature 116: 511

    Article  Google Scholar 

  • Parker LN, Chang S, Odell WD (1978) Adrenal androgens in patients with chronic marked elevation of prolactin. Clin Endocrinol 8: 1

    Article  CAS  Google Scholar 

  • Pearce JM, McGarrick G, Chamberlain GVP, Jeffcoate SL (1980) Lack of effect of interview and gynaecological examination on plasma levels of prolactin and cortisol. Br J Obstet Gynaecol 87: 366

    PubMed  CAS  Google Scholar 

  • Peters F, Schuth W, Breckwoldt M (1982) Ist die Palpation der Mamma ein Störfaktor für die Prolaktinbestimmung? Geburtshilfe Frauenheilkd 42: 223

    Article  PubMed  CAS  Google Scholar 

  • Priou A, Bruder N, Bégou D et al. (1995) Glycosylated and non-glycosylated prolactin forms are increased after opioid administrations as part of surgical anaesthesia. Clin Endocrinol 43: 213

    Article  CAS  Google Scholar 

  • Quigley ME, Sheehan KL, Casper RF, Yen SSC (1980) Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab 50: 427

    Article  PubMed  CAS  Google Scholar 

  • Rjosk HK, Fahlbusch R, von Werder K (1982) Influence of pregnancies on prolactinomas. Acta Endocrinol (Copenh) 100: 337–346

    CAS  Google Scholar 

  • Rjosk HK, von Werder K, Fahlbusch R (1976) Hyperprolaktinämische Amenorrhoe. Geburtshilfe Frauenheilkd 36: 575

    PubMed  CAS  Google Scholar 

  • Rossmanith WG (1994) Neuroendokrine Steuerung menschlicher Reproduktion. Ullstein Mosby, Wiesbaden, S. 15

    Google Scholar 

  • Rossmanith WG, Boscher S, Ulrich U, Benz R (1993) Chronobiology of prolactin secretion in women: diurnal and sleep-related variations in the pituitary lactotroph sensitivity. Neuroendocrinology 58: 263

    Article  PubMed  CAS  Google Scholar 

  • Rossmanith WG, Hohl B, Lüttke B (1995) Thyrotropin (TSH) and prolactin (PRL) secretion in lactating and non-lactating women. Gynecol Endocrinol 9: 181

    Article  PubMed  CAS  Google Scholar 

  • Rossmanith WG, Scherbaum WA (1994) Die Schilddrüse und ihre Bedeutung für die weibliche Reproduktion. Dtsch ärztebl 91: A5362

    Google Scholar 

  • Rossmanith WG, Yen SSC, Rasmussen DD (1989) Synchronous pulsatile release of luteinzing hormone and immunoreactive beta-endorphin from the human pituitary in vitro. J Neuroendocrinology 2: 91

    Article  Google Scholar 

  • Ruiz-Velasco V (1984) Pregnancy in hyperprolactinemia. Fertil Steril 41: 793

    PubMed  CAS  Google Scholar 

  • Schneider HPG, Bohnet HG (1977) Hyperprolaktinämische Amenorrhoe und Anovulation. Gynäkologe 10: 84

    Google Scholar 

  • Schneider HPG, Hanker JP (1988) Zyklusstörung und Diagnostik der funktionell gestörten Fertilität. In: Schneider HPG, Lauritzen C, Nieschlag E (Hrsg.) Grundlagen und Klinik der menschlichen Fortpflanzung. De Gruyter, Berlin, S 449

    Google Scholar 

  • Seppälä M, Hirvonen E (1975) Raised serum prolactin levels associated with hirsutism and amenorrhoea. Br Med J 4: 144

    Article  PubMed  Google Scholar 

  • Sinha YN (1995) Structural variants of prolactin: occurrence and physiological significance. Endocrine Rev 16: 354

    CAS  Google Scholar 

  • Sluijmer AV, Lappöhn RE (1992) Clinical history and outcome of 59 patients with idiopathic hyperprolactinemia. Fertil Steril 58: 72

    PubMed  CAS  Google Scholar 

  • Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87: 5410–5415

    Article  PubMed  CAS  Google Scholar 

  • Soule SG, Jacobs HS (1995) Prolactinomas: present day management. Br J Obstet Gynecol 102: 178

    CAS  Google Scholar 

  • Spark RF, Baker R, Bienfang DC, Bergland R (1982) Reduktion von Hypophysentumoren durch Bromocriptin. Requiem für chirurgische Eingriffe an der Hypophyse? JAMA (Dtsch Ausgabe) 1: 483

    Google Scholar 

  • Speroff L, Glass RH, Kase NG (1994) Clinical gynecologic endocrinology and infertility. Lippincott, Williams & Wilkins, Philadelphia, p 73

    Google Scholar 

  • Tyson JE, Zacur HA, Huth J, Chapanis N (1992) Hyperprolactinemia blunts awareness of distress and depression: evidence for a specific behavioral and environmental setting for galactorrhea-amenorrhea. Sem Reprod Endocrinol 10: 246

    Article  Google Scholar 

  • Vermeulen A, Suy E, Rubens R (1977) Effect of prolactin on plasma DHEA (s) levels. J Clin Endocrinol Metab 44: 1222

    Article  PubMed  CAS  Google Scholar 

  • von Werder K (1991) Therapie von Mikro-und Makroprolaktinomen. Dtsch Med Wschr 116: 25–27

    Google Scholar 

  • von Werder K, Eversmann T, Rjosk HK, Fahlbusch R (1982) Treatment of hyperprolactinemia. In: Ganong WF, Martini L (eds) Frontiers in neuroendocrinology. Raven, New York, p 123

    Google Scholar 

  • Waters MJ, Lusins S, Friesen HG (1984) Immunological and physiochemical evidence for tissue specific prolactin receptors in the rabbit. Endocrinology 114: 1

    Article  Google Scholar 

  • Weise HC, Moltz L, Bispink G, Leidenberger F (1989) Rationelle hormonale Diagnostik der Oligomenorrhö. Geburtshilfe Frauenheilkd 49: 694

    Article  PubMed  CAS  Google Scholar 

  • Wenzel KW (1981) Pharmacological interference with in vitro tests of thyroid function. Metabolism 30: 717

    Article  PubMed  CAS  Google Scholar 

  • Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhäuser MH (2008) Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril 89: 927–933

    Article  PubMed  CAS  Google Scholar 

  • Yazigi RA, Quintero CH, Salameh WA (1997) Prolactin disorders. Fertil Steril 67: 215–225

    Article  PubMed  CAS  Google Scholar 

  • Yen SSC (1996) Prolactin in human reproduction. In: Yen SSC, Jaffe RB (eds) Reproductive endocrinology. Saunders, Philadelphia, p 237

    Google Scholar 

  • Yuen BH (1978) Bromocriptine, pituitary tumours, and pregnancy. Lancet 2: 14

    Google Scholar 

  • Yuen BH (1992) Etiology and treatment of hyperprolactinemia. Sem Reprod Endocrinol 10: 228

    Article  Google Scholar 

  • Zacur HA, Foster GV (1992) Hyperprolactinemia and polycystic ovarian syndrome. Sem Reprod Endocrinol 10: 236

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Gynäkologische Endokrinologie, Reproduktionsmedizin und Humangenetik, Hemauer Straße 1, 93047, Regensburg

    Monika Bals-Pratsch Priv.-Doz. Dr. med.

Authors
  1. Monika Bals-Pratsch Priv.-Doz. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lokstedter Damm 15, 22453, Hamburg

    Freimut Leidenberger

  2. Abt. für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsklinikum Heidelberg, Voßstraße 9, 69115, Heidelberg

    Thomas Strowitzki

  3. Klinik für Frauenheilkunde und Geburtshilfe der Universität Regensburg am Caritas-Krankenhaus St. Josef, Landshuter Straße 65, 93053, Regensburg

    Olaf Ortmann

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Bals-Pratsch, M. (2009). Störungen des Prolaktinhaushalts. In: Leidenberger, F., Strowitzki, T., Ortmann, O. (eds) Klinische Endokrinologie für Frauenärzte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-89760-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-89760-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-89759-0

  • Online ISBN: 978-3-540-89760-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation